Laïla‐Aïcha Hanafi

CD19 CAR–T cells of defined CD4+:CD8+ composition in adult B cell ALL patients

Cameron J. Turtle, Laïla‐Aïcha Hanafi, Carolina Berger et al. · Journal of Clinical Investigation · 2016 · 2.1K citations · Full text

Medicine, Immunology, Oncology +17

Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells

Juliane Gust, Kevin A. Hay, Laïla‐Aïcha Hanafi et al. · Cancer Discovery · 2017 · 1.4K citations · Full text

Life Sciences, Immunology, Oncology +17

Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor–modified T-cell therapy

Kevin A. Hay, Laïla‐Aïcha Hanafi, Daniel Li et al. · Blood · 2017 · 1.1K citations · Full text

Life Sciences, Cell Biology, Immunology +16

Immunotherapy of non-Hodgkin’s lymphoma with a defined ratio of CD8 ⁺ and CD4 ⁺ CD19-specific chimeric antigen receptor–modified T cells

Cameron J. Turtle, Laïla‐Aïcha Hanafi, Carolina Berger et al. · Science Translational Medicine · 2016 · 1K citations

Medicine, Immunology, Oncology +17

Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy

Rebecca Gardner, David Wu, Sindhu Cherian et al. · Blood · 2016 · 749 citations · Full text

Life Sciences, Hematology, Immunology +14